newsfilter
← Latest News
GlobeNewswire·

Dianthus Therapeutics, Inc. Announces Proposed $400 Million Underwritten Public Offering

NEW YORK and WALTHAM, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (NASDAQ:DNTH) ("Dianthus" or the "Company"), a clinical-stage biotechnology company dedicated to developing next-generation